Topics

Companies Related to "interbacterial toxin inhibits target cell growth synthesizing ppApp" [Most Relevant Company Matches] RSS

16:50 EST 10th December 2019 | BioPortfolio

Here are the most relevant search results for "interbacterial toxin inhibits target cell growth synthesizing ppApp" found in our extensive corporate database of over 50,000 company records.

Showing "interbacterial toxin inhibits target cell growth synthesizing ppApp" Companies 1–25 of 3,700+

Relevant

NewBiotics

NewBiotics Inc. is a pharmaceutical developer of breakthrough drugs to treat cancer and infectious disease. The privately held company is applying its Enzyme Catalyzed Therapeutic Activation (ECTA) technology to develop a new generation of pharmaceuticals that transform drug resis-tance into therapeutic advantage. Unlike conventional agents that kill diseased cells by enzyme inhibition – with to...


Toxin Alert Inc

Toxin Alert's patented diagnostic tests for food freshness and food safety are rapidly approaching commercialization.Development of Toxin Guard™ technology is proceeding at the company's Guelph laboratory, with pre-commercial scale antibodies being produced in bioreactors. Commercial scale antibody production will be sourced from plants using plantibody™ technology.The company's strategy...The...

True North Therapeutics

True North Therapeutics is a biotechnology company developing novel therapies that selectively target the Complement pathway of the immune system to address fundamental mechanisms in diseases with high unmet need, including rare diseases. The company’s lead monoclonal antibody drug candidate, TNT009, selectively inhibits a target in the Classical Comp...


True North Therapeutics, Inc.

True North Therapeutics is a biotechnology company developing novel therapies that selectively target the Complement pathway of the immune system to address fundamental mechanisms in diseases with high unmet need, including rare diseases. The company’s lead monoclonal antibody drug candidate, TNT009, selectively inhibits a target in the Classical Comp...

Protox Therapeutics Inc.

Protox Therapeutics is a product-focused development-stage company and a leader in advancing novel, targeted protein toxin therapeutics for the treatment of cancer and other proliferative diseases. Through the company’s INxin™ and PORxin™ technology platforms, therapeutic candidates are generated by engineering the naturally occurring toxins, Pseudomonas exotoxin and proaerolysin. These drug...

Gemin X Pharmaceuticals, Inc.

Gemin X Pharmaceuticals, Inc., specializes in the discovery and development of novel target-based cancer therapeutics. Gemin X's lead product, obatoclax (GX15-070), is a small molecule, pan-inhibitor of Bcl-2 proteins and is currently in Phase 2 clinical trials. Gemin X's second compound GMX1777, is a potent, small molecule that specifically inhibits nicotinamide phosphoribosyl transferase (NAMPRT...

Target BioScience AG

Target BioScience AG is a consulting firm focused exclusively on the pharmaceutical and biotechnology fields. Our trademark is our highly practical approach. Target BioScience AG was originally founded by Dr. Meinrad Good in 1993 as the pharmaceutical and biotech consulting company "BPB". In 2000, the company was re-established as "Target BioScience AG" in response to growth in international opera...

Kinex Pharmaceuticals, LLC

Kinex Pharmaceuticals is developing next generation anti-cancer drugs that target the molecular basis of disease. The Company uses a proprietary technology platform to generate compounds that inhibit the Protein Kinase and Phosphatase family of proteins.Protein kinases and phosphatases are families of proteins that are intimately involved in transmitting signals across the cell membrane. They cont...

Transgalactic Limited

A microbiology reader runs microbiology tests automatically, simultaneously monitoring the growth of microorganisms in 200 wells. Corresponding growth curves and microbiological calculations are shown in MS Excel. Any experiment where the growth of bacteria, yeast, fungi, cell or phage are to be followed kinetically in a liquid growth medium can be performed.

Automated Cell, Inc

Automated Cell, Inc is focused on the discovery and development of monoclonal antibody therapeutics for the treatment of cancer. Our unique and proprietary technology allows us to rapidly and inexpensively identify human antibodies that have relevant biological function in a specific disease. Our approach is target-independent and does not require prior knowledge of the target or mechanism. We ant...

ProlX Pharmaceuticals, Corp.

ProlX Pharmaceuticals (ProlX) is a biopharmaceutical company dedicated to the discovery of novel therapeutics for the treatment of cancer. The Company is building a diversified pipeline utilizing a target-directed combinatorial chemistry approach to accelerate the design and development of small molecule drug leads. ProlX’s drug discovery program is focused on targeting redox regulation and sur...

OptiCell Inc.

OptiCell is a new concept in cell culture devices that revolutionizes the cell culture process.OptiCell accommodates the full range of cellculture activities from cell growth and magnetic cell separation to transfection in a device with the footprint of a standard microtiter plate.OptiCell can also be used for the production of monoclonal antibodies, cytokines, and other secreted molecules.

Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism pr...

Medytox, Inc.

Medytox, Inc. is the only biopharmaceutical company in the world to have three different types of botulinum toxin products (Neuronox, INNOTOX, Coretox), and Neuronox is only the fourth botulinum toxin therapeutic product approved anywhere in the world. All products have been developed by in-house R&D. Since the approval of Neuronox, Medytox has continued m...

DOR BioPharma

DOR BioPharma, Inc. is a biopharmaceutical company addressing life-threatening side effects of cancer and cancer treatments, serious gastrointestinal diseases and disorders, and biomedical countermeasures. Our lead product, orBec® (oral beclomethasone dipropionate), is a potent, locally-acting corticosteroid being developed for the treatment of gastrointestinal Graft-versus-Host disease (GI GVHD)...

4SC AG

4SC AG (ISIN DE0005753818) is a drug discovery and development company focused on autoimmune and cancer indications. Vidofludimus (4SC-101), a small molecule, is currently in a Phase IIb study in rheumatoid arthritis and a Phase IIa exploratory study in inflammatory bowel disease. The company's lead oncology compound, resminostat (4SC-201), a pan histone d...

NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals is focused on neurodegenerative diseases that affect millions of patients worldwide. The company’s novel lead candidate NB-01 is a potential treatment for diabetic neuropathic pain. NB-01 increases levels of the neurotrophin, nerve growth factor (NGF). NGF inhibits nerve cell death and promotes nerve regeneration. The compound...

Minerva Biotechnologies

Minerva Biotechnologies is a pioneer in the field of stem cells and cancer stem cells. Minerva was first to discover that cancer cells hijack an otherwise normal stem cell growth mechanism, involving a growth factor receptor called MUC1* (pronounced muk 1 star). By studying human stem cells in parallel with human cancer cells, Minerva scientists figured ou...

Target Health Inc. & LifeOnKey Inc.

Target Health, (www.targethealth.com) established in 1993, is a full service eCRO with full-time staff dedicated to all aspects of drug and device development. Areas of expertise include Regulatory Affairs, strategic planning, IND, IDE, eCTD NDA, PMA and 510(k) submissions, Clinical Trial Monitoring and Project Management, Biostatistics, Data Management, E...

Globe Laboratories

Globe Labs manufactures and sells high quality, low cost human therapeutic proteins, human growth hormones, enzymes, research laboratory cytokines, chemokines & their respective inhibitors/antagonists for research and veterinary use. We are also manufacturers of bulk quantities for other pharmaceutical companies worldwide. Globe Labs is proud to have the largest antagonist product list in the worl...

Century Therapeutics

Century Therapeutics is harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. Century’s genetically-engineered, iPSC-derived immune effector cell products are designed to specifically target hematologic and solid cancers. Its commitment to developing off-the-shelf cell therapies will expand patient access and provides an unparalleled opportunity t...

Solentim

Commercial cell line development for biopharmaceutical production is a high value process which is intrinsically expensive and takes a significant amount of time. Solentim is dedicated to the development of innovative tools to shorten steps in the upstream cell line development workflow and facilitate cell line scale-up. The Cell Metric™ product range...

Target Corp.

Minneapolis-based Target Corporation (NYSE:TGT) serves guests at 1,764 stores across the United States and at Target.com. The company plans to open its first stores in Canada in 2013. In addition, the company operates a credit card segment that offers branded proprietary credit card products. Since 1946, Target has given 5 percent of its income through com...

G-Zero Therapeutics

G-Zero Therapeutics, Inc., a privately held pharmaceutical company, founded in 2008 by Dr. Norman Sharpless, University of North Carolina at Chapel Hill, Dr. Kwok-Kin Wong, Harvard Medical School, and Dr. John Chant, is focused on the discovery and development of novel small molecules for use in biodefense applications and cancer therapy. These mole...

Cell Microsystems

Cell Microsystems is an early growth stage company that develops, manufactures, and markets innovative products for single cell biology. The Company’s proprietary CellRaft™ Technology enables high-efficiency sorting and isolation of single cells under standard culture conditions resulting in unperturbed phenotypes and high viability. Coupled with the ...


More From BioPortfolio on "interbacterial toxin inhibits target cell growth synthesizing ppApp"

Quick Search

Corporate Database Quicklinks